Press release
Single-Use Bioreactors Market to Reach USD 14.9 Billion by 2030
Single-Use Bioreactors
Single-use bioreactors (SUBs) enable flexible, contamination-resistant, and cost-efficient production-making them essential for mAbs, vaccines, recombinant proteins, viral vectors, and personalized cell therapies.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73534
Key Takeaways
• Market Size 2023: USD 5.4 billion
• Market Size 2030: USD 14.9 billion
• CAGR (2024-2030): 15.4%
• Largest Segment: Wave-induced and stirred-tank bioreactors
• Primary Demand Drivers: Biologics expansion, advanced therapies, and rapid adoption by CDMOs
Market Story
Single-use bioreactors have transformed bioprocessing by overcoming the limitations of stainless-steel systems-offering:
• Fast turnaround with zero cleaning/sterilization
• Lower contamination risk
• High flexibility for multiproduct facilities
• Reduced capital and operating costs
• Ease of scale-out for cell & gene therapies
• Rapid deployment and modularity
They are now indispensable across:
• Monoclonal antibody (mAb) production
• Vaccines & viral vector manufacturing
• Cell & gene therapy (CAR-T, stem cells)
• mRNA and recombinant protein production
• Perfusion & continuous bioprocessing
• Bioprocess development and pilot-scale studies
The surge in personalized and small-batch therapies significantly boosts demand for single-use systems.
Market Segments
By Type of Bioreactor
• Stirred-Tank Single-Use Bioreactors (Largest Segment)
• Wave-Induced Single-Use Bioreactors
• Hybrid Single-Use Bioreactors
• SUB Accessories & Consumables
Stirred-tank SUBs dominate due to familiarity, scalability, and integration with automation.
By Cell Culture Type
• Mammalian Cell Culture (Largest Application)
• Microbial Cell Culture
• Insect Cell Culture
• Plant Cell Culture
• Stem Cell & Primary Cell Culture
Mammalian cell culture dominates biologics and viral vector manufacturing.
By Application
• Monoclonal Antibodies (mAbs) (Largest Application)
• Vaccines & Viral Vector Production
• Cell & Gene Therapy Manufacturing
• Recombinant Proteins & Enzymes
• mRNA-Based Therapeutics
• Bioprocess Development & R&D
Cell and gene therapy production is the fastest-growing area of adoption.
By Capacity
• Up to 50 L
• 50-500 L
• 500-1500 L (Largest Segment)
• Above 1500 L (Emerging Trend)
High-capacity SUBs (1000-2000 L) are increasingly used for commercial-scale biologics.
By End User
• Biopharmaceutical Companies (Largest End User)
• CDMOs (Fastest Growing Segment)
• CROs & Research Institutes
• Cell Therapy Centers
• Vaccine Manufacturers
CDMOs drive major demand due to multi-client flexible manufacturing requirements.
Explore Full Report here: https://exactitudeconsultancy.com/reports/73534/single-use-bioreactors-market
Recent Industry Developments
• 2024 - Sartorius expanded its BIOSTAT® STR single-use platform with advanced automation features.
• 2023 - Cytiva launched next-gen single-use XcellerexTM stirred-tank bioreactors with improved process control.
• 2023 - Thermo Fisher Scientific upgraded its HyPerformaTM SUB line for intensified and perfusion bioprocessing.
• 2023 - Merck KGaA introduced high-capacity single-use bioreactors enabling scalable mAb and vaccine production.
• 2023 - PBS Biotech expanded its single-use bioreactor solutions for cell therapy manufacturing.
Expert Quote
"Single-use bioreactors offer flexibility, sterility, and scalability-making them the preferred choice for modern biomanufacturing, especially in mAbs, vaccines, and advanced cell therapies."
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Key Market Drivers
1. Growth of Biologics & Biosimilars
mAbs, recombinant proteins, and vaccines require efficient, contamination-free manufacturing.
2. Rising Adoption of Cell & Gene Therapies
Single-use platforms are ideal for small-batch, personalized therapies.
3. Operational Efficiency & Cost Reduction
No cleaning, sterilization, or CIP/SIP steps cuts costs and speeds production.
4. Expansion of CDMOs
CDMOs prefer SUBs due to rapid changeovers and multiproduct flexibility.
5. Increasing Use in Continuous Bioprocessing
SUB-enabled perfusion systems support intense, real-time continuous production.
Forecast Outlook (2024-2030)
Key trends shaping the market include:
• SUB integration with automation & AI-based process control
• Expansion of high-volume (1500-4000 L) disposable bioreactors
• Single-use perfusion bioreactors for continuous manufacturing
• Hybrid stainless + single-use facility designs
• Rapid growth in advanced therapy manufacturing
By 2030, single-use bioreactors will dominate early-stage and mid-scale biologics production facilities worldwide, with growing penetration in commercial-scale setups.
Regional Insights
North America
Largest market driven by strong biologics and cell therapy production capabilities.
Europe
High adoption due to advanced CDMOs and rapid biomanufacturing modernization.
Asia-Pacific (Fastest Growing Region)
China, India, South Korea, and Singapore are expanding single-use-based biomanufacturing hubs.
Latin America & Middle East
Growing biologics and vaccine production drives gradual adoption.
Conclusion
The Single-Use Bioreactors Market is positioned for strong growth as global biopharma adopts flexible, scalable, contamination-resistant production systems. With increasing demand for biologics, vaccines, and personalized therapies, single-use bioreactors will continue to play a critical role in next-generation GMP manufacturing.
This report is also available in the following languages : Japanese (使い捨てバイオリアクター市場), Korean (일회용 바이오리액터 시장), Chinese (一次性生物反应器市场), French (Marché des bioréacteurs à usage unique), German (Markt für Einweg-Bioreaktoren), and Italian (Mercato dei bioreattori monouso), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/73534
Related Reports
Fermenters and Bioreactors Market
https://exactitudeconsultancy.com/reports/73517/fermenters-and-bioreactors-market
Small Scale Bioreactors Market
https://exactitudeconsultancy.com/reports/73521/small-scale-bioreactors-market
Bioreactors Market
https://exactitudeconsultancy.com/reports/29878/bioreactors-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Single-Use Bioreactors Market to Reach USD 14.9 Billion by 2030 here
News-ID: 4293157 • Views: …
More Releases from Exactitude Consultancy
Automated Cell Processing System Market to Reach USD 8.41 Billion by 2030
The Global Automated Cell Processing System Market is growing rapidly as cell therapies, gene therapies, stem cell treatments, and advanced regenerative medicine move toward large-scale clinical and commercial adoption. According to Exactitude Consultancy, the market is projected to rise from USD 2.9 billion in 2023 to USD 8.41 billion by 2030, expanding at a robust CAGR of 16.4%.
Automated cell processing systems streamline and standardize cell isolation, expansion, activation, washing, concentration,…
Continuous Manufacturing Systems Market to Reach USD 2.98 Billion by 2030
The Global Continuous Manufacturing Systems Market is expanding rapidly as industries shift from traditional batch processing to real-time, efficient, and automation-driven continuous production. According to Exactitude Consultancy, the market is projected to increase from USD 1.42 billion in 2023 to USD 2.98 billion by 2030, growing at a notable CAGR of 10.6%.
Continuous manufacturing systems are increasingly deployed in pharmaceuticals, chemicals, food processing, and advanced materials due to their benefits in…
Continuous Bioprocessing Market to Reach USD 18.6 Billion by 2030
The Global Continuous Bioprocessing Market is accelerating as biologics, biosimilars, vaccines, and emerging cell & gene therapies increasingly adopt continuous, real-time, and highly controlled manufacturing approaches. According to Exactitude Consultancy, the market is expected to grow from USD 6.2 billion in 2023 to USD 18.6 billion by 2030, registering an impressive CAGR of 16.9%.
Continuous bioprocessing enables uninterrupted production, improved efficiency, reduced footprint, lower costs, and superior product consistency compared to…
Bioprocess Automation Market to Reach USD 33.4 Billion by 2030
The Global Bioprocess Automation Market is experiencing rapid expansion as biologics, biosimilars, cell therapies, gene therapies, and vaccine manufacturing increasingly rely on automated, connected, and highly controlled bioprocessing systems. According to Exactitude Consultancy, the market is projected to grow from USD 12.4 billion in 2023 to USD 33.4 billion by 2030, achieving a strong CAGR of 14.2%.
Automation across upstream, downstream, and fill-finish workflows ensures higher productivity, reduced contamination, improved batch…
More Releases for Bioreactor
Water Pollution Surge Spurs Growth In The Membrane Bioreactor Market: An Emergin …
The Membrane Bioreactor Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Membrane Bioreactor Market?
The market size for membrane bioreactors has experienced swift expansion in the last few years. The forecast predicts an escalation from $4.24 billion in 2024…
Technological Innovations Propel The Membrane Bioreactor Market Forward Trend: A …
What industry-specific factors are fueling the growth of the membrane bioreactor market?
The escalation in water contamination levels is playing a substantial role in propelling the membrane bioreactor market's expansion. The phenomenon of water pollution is characterized by the release of harmful chemicals or organisms into bodies of water such as rivers, lakes, and seas. Such instances of water pollution sprout from the lack of clean, potable water. Amidst the surge…
Cellbag Bioreactor Chambers Market - Seamless Cell Culturing: Cellbag Bioreactor …
Newark, New Castle, USA: The "Cellbag Bioreactor Chambers Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Cellbag Bioreactor Chambers Market: https://www.growthplusreports.com/report/cellbag-bioreactor-chambers-market/8938
This latest report researches the industry structure,…
Microbial Bioreactor Market
The Global Microbial Bioreactor Market is expected to grow at a CAGR of 20.1% during the forecasting period (2022-2029).
Micro bioreactors serve as a multitude of scale-down needs for bioprocesses based on mammalian cells. Microbioreactor technology has allowed for rapid advancements in biotechnology process development and investigation of various biological systems from industrial biotechnology and pharmaceutical biotechnology. Micro bioreactors range in complexity from simple micro-tier-based systems to complex automated parallel bioreactors…
Global Membrane Bioreactor Market - Forecasts to 2026
The findings reviewed by GME stated that the Global Membrane Bioreactor Market will expand with a CAGR value of 7.0 percent from 2021 to 2026. The Membrane Bioreactor (MBR) market will expand rapidly due to increased ecological concerns about wastewater management and dwindling freshwater resources., population growth, shifting consumer habits, global warming, urbanization, and industrialization.
Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on…
Single Use Bioreactor Market Assessment 2017-2021
Single use bioreactors are witnessing rapid market growth due to increasing applications in production of antibodies, vaccines, recombinant proteins, growth factors and others. Single use bioreactors are not only used in pharmaceutical companies, but also in biotechnology research laboratories and contract manufacturing organizations. Single use bioreactors assure sterile conditions to quickly initiate production. This greatly reduced chances of cross contamination and increases productivity. Shorter turnaround time due to ease of…
